US Patent Issued to AstraZeneca on Sept. 29 for "N-(2-(3-cyano-2-azabicyclo[3.1.0hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides" (Swedish Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,223, issued on Sept. 29, was assigned to AstraZeneca AB (Sodertalje, Sweden).

"N-(2-(3-cyano-2-azabicyclo[3.1.0hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides" was invented by Jonas Branalt (Gothenburg, Sweden), Maria Johansson (Gothenburg, Sweden), Anneli Nordqvist (Gothenburg, Sweden), Gavin O'Mahony (Gothenburg, Sweden) and Marianne Swanson (Gothenburg, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds having the structure of Formula (I):and pharmaceutically acceptable salts thereof, wherein R2, R3, R5, R6, R7, and R8 are as defined in the specification; pharmaceutical compositions comprising such compounds and salts; use of such c...